NCT04958746View on ClinicalTrials.gov

Phase III Clinical Trial Evaluating the Efficacy and Safety of Ciprofol Injection for the Induction of Sedation/Anesthesia in Subjects Undergoing Gynecological Outpatient Surgeries

PHASE3CompletedINTERVENTIONAL

Enrollment

135

Participants

Timeline

Start Date

July 26, 2021

Primary Completion Date

September 29, 2021

Study Completion Date

September 30, 2021

Conditions

Gynecological Outpatient Surgery

Interventions

DRUG

Ciprofol

intravenous bolus

DRUG

Propofol

intravenous bolus

Trial Locations (1)

Unknown

Peking University First Hospital, Beijing

All Listed Sponsors

lead

Haisco Pharmaceutical Group Co., Ltd.

INDUSTRY

NCT04958746 - Phase III Clinical Trial Evaluating the Efficacy and Safety of Ciprofol Injection for the Induction of Sedation/Anesthesia in Subjects Undergoing Gynecological Outpatient Surgeries | Biotech Hunter | Biotech Hunter